Skip to Main

Ivan D’Avanzo is a member of BCG X, Boston Consulting Group’s tech build and design division. He works with biopharma and medtech executives on digital and AI topics covering strategy and technical solution development, including omni-channel customer engagement and next best action (NBA), next-generation launch (digital launch control tower), AI-driven segmentation and targeting, digital Marketing ROI analytics, patient identification based on real world data (RWD) to match patients with the right therapies, digital and analytics strategy and transformation, digital and analytics talent strategy, and health care data strategy and governance.

Before joining BCG, Ivan was a real-time analytics engineer for Ferrari's Formula 1 team.

AREAS OF EXPERTISE

EDUCATION

  • MBA, finance and strategic management, University of Chicago Booth School of Business
  • BA, telecommunications engineering, Universita’ di Napoli Federico II

HONORS AND AWARDS

  • Member and Young Leader, Council for the United States and Italy

Publications and Videos

""

Rethinking Pharma’s Commercial Model

BCG’s new data-driven, high-efficiency model allows sales reps to offer health care providers a personalized sales experience—unlocking tremendous shareholder value.
For Physicians and Pharma, Hybrid Engagement Is the New Normal Hero Rectangle

For Physicians and Pharma, Hybrid Engagement Is the New Normal

BCG’s latest survey of physicians and their preferences for patient and pharma company interactions finds a hybrid model of in-person and virtual engagement taking shape.
How Pharma Is Personalizing Physician Engagement - rectangle

How Biopharma Is Personalizing Physician Engagement

Powerful new models are in the works, but effective implementation depends on building the right capabilities and enablers.
how-ai-helped-get-the-right-treatment-to-cancer-patients2880x1620px-tcm9-235330.jpg

How AI Helped Get the Right Treatment to Cancer Patients

When biopharma companies apply data and analytics, they can make smarter commercial decisions, get better treatment information to physicians, and help save lives.